SETD8 involved in the progression of inflammatory bowel disease via epigenetically regulating p62 expression.

Our findings elucidate an epigenetic mechanism by which SETD8 regulates the p62 expression and restrains the inflammatory response in colitis. Our result suggests that targeting SETD8 may be a promising therapy for IBD.